echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Food News > Nutrition News > Largest longitudinal study to date shows antihypertensive drugs improve survival in pancreatic cancer patients

    Largest longitudinal study to date shows antihypertensive drugs improve survival in pancreatic cancer patients

    • Last Update: 2022-03-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Pancreatic cancer is an extremely difficult cancer to treat


    "High blood pressure drugs don't have many side effects -- for example, much less than chemotherapy -- but our data suggest that they may prolong the lives of people with pancreatic cancer," said Dr.


    Led by Dr.


    Early studies in animals suggest that arb-type therapies -- including drugs like valsartan and losartan -- and ACE inhibitors -- including benazepril, ramipril or lisinopril -- may slow the Pancreatic cancer growth


    Drs


    Their results showed that pancreatic cancer patients who also took ARBs had a 20 percent lower mortality rate, while those who underwent surgery had a 28 percent lower mortality rate


    "We cannot predict to what extent these drugs will prolong life," Dr.


    Dr.


    article title

    Angiotensin blockade therapy and survival in pancreatic cancer: a population study


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.